Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

NASDAQ:CBAT - Nasdaq - US14986C1027 - Common Stock - Currency: USD

0.86  -0.01 (-1.1%)

After market: 0.853 -0.01 (-0.81%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CBAT. CBAT was compared to 93 industry peers in the Electrical Equipment industry. While CBAT is still in line with the averages on profitability rating, there are concerns on its financial health. CBAT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CBAT had positive earnings in the past year.
CBAT had a positive operating cash flow in the past year.
In the past 5 years CBAT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CBAT reported negative operating cash flow in multiple years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

CBAT has a better Return On Assets (3.93%) than 78.26% of its industry peers.
The Return On Equity of CBAT (8.79%) is better than 80.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.02%, CBAT belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
Industry RankSector Rank
ROA 3.93%
ROE 8.79%
ROIC 11.02%
ROA(3y)6.23%
ROA(5y)0.39%
ROE(3y)11.99%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

1.3 Margins

CBAT's Profit Margin of 5.56% is fine compared to the rest of the industry. CBAT outperforms 79.35% of its industry peers.
The Operating Margin of CBAT (11.11%) is better than 79.35% of its industry peers.
CBAT's Gross Margin of 27.21% is fine compared to the rest of the industry. CBAT outperforms 64.13% of its industry peers.
CBAT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.11%
PM (TTM) 5.56%
GM 27.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.6%
GM growth 5YN/A
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

3

2. Health

2.1 Basic Checks

CBAT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CBAT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CBAT has been increased compared to 5 years ago.
CBAT has a worse debt/assets ratio than last year.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

CBAT has an Altman-Z score of 0.60. This is a bad value and indicates that CBAT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.60, CBAT perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
CBAT has a debt to FCF ratio of 0.79. This is a very positive value and a sign of high solvency as it would only need 0.79 years to pay back of all of its debts.
CBAT has a Debt to FCF ratio of 0.79. This is amongst the best in the industry. CBAT outperforms 92.39% of its industry peers.
CBAT has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.20, CBAT is in line with its industry, outperforming 54.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.79
Altman-Z 0.6
ROIC/WACC1.9
WACC5.81%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

CBAT has a Current Ratio of 0.85. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.85, CBAT is doing worse than 82.61% of the companies in the same industry.
A Quick Ratio of 0.69 indicates that CBAT may have some problems paying its short term obligations.
With a Quick ratio value of 0.69, CBAT is not doing good in the industry: 76.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.69
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

6

3. Growth

3.1 Past

CBAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 254.55%, which is quite impressive.
The Revenue has been growing slightly by 2.32% in the past year.
CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.98% yearly.
EPS 1Y (TTM)254.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.71%
Revenue 1Y (TTM)2.32%
Revenue growth 3Y75.84%
Revenue growth 5Y52.98%
Sales Q2Q%-22.68%

3.2 Future

The Earnings Per Share is expected to grow by 91.29% on average over the next years. This is a very strong growth
CBAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.79% yearly.
EPS Next Y375%
EPS Next 2Y65.83%
EPS Next 3Y91.29%
EPS Next 5YN/A
Revenue Next Year-2.78%
Revenue Next 2Y5.17%
Revenue Next 3Y15.79%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.06, the valuation of CBAT can be described as very cheap.
Based on the Price/Earnings ratio, CBAT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
CBAT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
CBAT is valuated cheaply with a Price/Forward Earnings ratio of 7.66.
Based on the Price/Forward Earnings ratio, CBAT is valued cheaper than 96.74% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CBAT to the average of the S&P500 Index (22.70), we can say CBAT is valued rather cheaply.
Industry RankSector Rank
PE 5.06
Fwd PE 7.66
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CBAT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CBAT is cheaper than 100.00% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than CBAT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.27
EV/EBITDA 1.22
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBAT's earnings are expected to grow with 91.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y65.83%
EPS Next 3Y91.29%

0

5. Dividend

5.1 Amount

CBAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (2/21/2025, 8:05:25 PM)

After market: 0.853 -0.01 (-0.81%)

0.86

-0.01 (-1.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-13 2025-03-13/bmo
Inst Owners2.07%
Inst Owner Change-97.3%
Ins Owners19.76%
Ins Owner Change0%
Market Cap77.33M
Analysts0
Price Target2.04 (137.21%)
Short Float %1.89%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.98%
Min EPS beat(2)-100%
Max EPS beat(2)-1.96%
EPS beat(4)1
Avg EPS beat(4)219.61%
Min EPS beat(4)-198.04%
Max EPS beat(4)1178.43%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-24.84%
Min Revenue beat(2)-25.12%
Max Revenue beat(2)-24.56%
Revenue beat(4)0
Avg Revenue beat(4)-16.06%
Min Revenue beat(4)-25.12%
Max Revenue beat(4)-6.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-85.71%
EPS NQ rev (3m)-85.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-38.71%
Revenue NQ rev (1m)-12.09%
Revenue NQ rev (3m)-12.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.3%
Valuation
Industry RankSector Rank
PE 5.06
Fwd PE 7.66
P/S 0.37
P/FCF 2.27
P/OCF 1.38
P/B 0.59
P/tB 0.59
EV/EBITDA 1.22
EPS(TTM)0.17
EY19.77%
EPS(NY)0.11
Fwd EY13.05%
FCF(TTM)0.38
FCFY44.12%
OCF(TTM)0.62
OCFY72.22%
SpS2.31
BVpS1.46
TBVpS1.45
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.93%
ROE 8.79%
ROCE 16.55%
ROIC 11.02%
ROICexc 12.91%
ROICexgc 12.96%
OM 11.11%
PM (TTM) 5.56%
GM 27.21%
FCFM 16.45%
ROA(3y)6.23%
ROA(5y)0.39%
ROE(3y)11.99%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.6%
GM growth 5YN/A
F-Score7
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.79
Debt/EBITDA 0.8
Cap/Depr 224.62%
Cap/Sales 10.47%
Interest Coverage 288.15
Cash Conversion 170.65%
Profit Quality 295.89%
Current Ratio 0.85
Quick Ratio 0.69
Altman-Z 0.6
F-Score7
WACC5.81%
ROIC/WACC1.9
Cap/Depr(3y)352.23%
Cap/Depr(5y)271.45%
Cap/Sales(3y)19.59%
Cap/Sales(5y)17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)254.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.71%
EPS Next Y375%
EPS Next 2Y65.83%
EPS Next 3Y91.29%
EPS Next 5YN/A
Revenue 1Y (TTM)2.32%
Revenue growth 3Y75.84%
Revenue growth 5Y52.98%
Sales Q2Q%-22.68%
Revenue Next Year-2.78%
Revenue Next 2Y5.17%
Revenue Next 3Y15.79%
Revenue Next 5YN/A
EBIT growth 1Y1959.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y329.17%
FCF growth 3YN/A
FCF growth 5Y52.56%
OCF growth 1Y183.91%
OCF growth 3YN/A
OCF growth 5Y39.73%